COST-EFFECTIVENESS ANALYSIS OF VACCINATION WITH 13-VALENT CONJUGATE (PCV13) AND 23-VALENT (PPV23) POLYSACCHARIDE PNEUMOCOCCAL VACCINES FOR ADULTS IN SWEDEN
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1218
https://www.valueinhealthjournal.com/article/S1098-3015(16)01286-9/fulltext
Section Title :
Infection - Cost Studies
Section Order :
717
First Page :
A216
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01286-9&doi=10.1016/j.jval.2016.03.1218